Nom du produit:N-(1,3-dimethyl-2,2-dioxo-1,3-dihydro-2lambda6,1,3-benzothiadiazol-5-yl)quinoxaline-2-carboxamide

IUPAC Name:N-(1,3-dimethyl-2,2-dioxo-1,3-dihydro-2λ⁶,1,3-benzothiadiazol-5-yl)quinoxaline-2-carboxamide

CAS:2034587-02-3
Formule moléculaire:C17H15N5O3S
Pureté:95%+
Numéro de catalogue:CM936045
Poids moléculaire:369.4

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2034587-02-3
Formule moléculaire:C17H15N5O3S
Point de fusion:-
Code SMILES:CN1C2=C(C=C(NC(=O)C3=CN=C4C=CC=CC4=N3)C=C2)N(C)S1(=O)=O
Densité:
Numéro de catalogue:CM936045
Poids moléculaire:369.4
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.